Cimarron E. Sharon

Long-term outcomes to neoadjuvant pembrolizumab based on pathological response for patients with resectable stage III/IV cutaneous melanoma

Cimarron E. Sharon, G.N. Tortorello, A.C. Huang et al. · Annals of Oncology · 2023 · 34 citations · Full text

Medicine, Clinical Sciences, Oncology +16

The prognostic significance of tumor-infiltrating lymphocytes for primary melanoma varies by sex

Andrew J. Sinnamon, Cimarron E. Sharon, Yun Song et al. · Journal of the American Academy of Dermatology · 2018 · 30 citations

Medicine, Immunology, Oncology +16

Association of Marital Status With T Stage at Presentation and Management of Early-Stage Melanoma

Cimarron E. Sharon, Andrew J. Sinnamon, Michael E. Ming et al. · JAMA Dermatology · 2018 · 30 citations · Full text

Medicine, Oncology, Surgery +12

Sentinel lymph node biopsy in patients with T1a cutaneous malignant melanoma: A multicenter cohort study

Adrienne B. Shannon, Cimarron E. Sharon, Richard J. Straker et al. · Journal of the American Academy of Dermatology · 2022 · 27 citations

Medicine, Oncology, Surgery +16

Sentinel lymph node biopsy status improves adjuvant therapy decision-making in patients with clinical stage IIB/C melanoma: A population-based analysis

Cimarron E. Sharon, Richard J. Straker, Phyllis A. Gimotty et al. · Journal of the American Academy of Dermatology · 2022 · 22 citations · Full text

Medicine, Oncology, Pathology +17